z-logo
open-access-imgOpen Access
How to optimize the treatment strategy for patients with EGFR-mutant stage IA lung adenocarcinoma: an international multidisciplinary team
Author(s) -
Yalei Zhang,
Jianfei Shen,
Charles B. Simone,
Federico Cappuzzo,
Kwun M. Fong,
Rafael Rosell,
Joe Y. Chang,
Luca Ampollini,
J. Isabelle Choi,
Jianxing He,
Tao Jiang
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.06.101
Subject(s) - medicine , oncology , lung cancer , adenocarcinoma , vinorelbine , stage (stratigraphy) , radiation therapy , adjuvant therapy , sabr volatility model , chemotherapy , cancer , cisplatin , paleontology , biology , volatility (finance) , stochastic volatility , financial economics , economics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom